WebSuprathel® 111823-US, 151823-US GUDID 04260184021475 Suprathel® is an absorbable, microporous membrane and alloplastic skin substitute for the treatment of wounds, split-skin donor sites, and burns as indicated hereinafter. ... WebMar 21, 2024 · Suprathel by Polymedics Aquacel Ag Extra Hydrofiber by ConvaTec Altrazeal by Uluru Duoderm by ConvaTec Bactigras by Smith & Nephew Biobrain by Smith & Nephew Mepitel by Molnlycke Aquacel by ConvaTec Kaltostat by ConvaTec Adaptic by Acelity or Jelonet by Smith & Nephew Tegaderm by 3 M Time to healing (mean number of days) …
Suprathel® Use During Prolonged Field Care to Promote Healing and
WebSuprathel® Intelligent Burn and Wound Dressing. Suprathel is an innovative biodegradable microporous membrane and alloplastic skin substitute for the treatment of scolds, partial and deep dermal burn wounds and other indications of large area of skin loss. Suprathel has been successfully used in the management of burns patients, donor sites ... WebOffice Manager at PolyMedics Innovations Inc Woodstock, Georgia, United States. 356 ... Visit our booth #203 and receive the latest clinical experiences on SUPRATHEL®, the ... howells \u0026 baird inc
&ODVV 8QFODVVLILHG - Food and Drug Administration
WebSUPRATHEL® is a Class III medical device distributed in 36 countries across five continents. To date, more than 20,000 patients have been successfully treated in over 300 burn centers. SUPRATHEL® is based on polylactic acid and as an elastic membrane it mimics the natural skin. While being permeable to oxygen and water vapor it provides a ... WebPolyMedics Innovations (PMI) is dedicated to advancing wound care for patients, physicians and societies through innovation and collaboration. Its proprietary Polylactide-Active-Membrane technology has advanced burn care since 2001 – Suprathel has been applied in wide over 75’000 cases and is being used in over 400 expert burn care centers ... WebJul 18, 2024 · The purpose of this study is to determine the effect to which Suprathel® (Polymedics Innovations GmbH, Denkendorf, Germany) can reduce the need for grafting compared to Standard of Care (SoC). Furthermore, the study intends to evaluate if Suprathel® allows for a reduction of reduction of pain, infection, provider workload, scar … hide apps on windows